The Cole Eye Institute Retina Summit took place on Friday, May 5, 2017

This Summit provides a comprehensive medical and surgical update in new advancements in retinal imaging critical to enhance the accuracy of diagnosis and to improve treatment outcomes for diseases of the retina and vitreoretinal interface.

Session Topics

OCT Angiography in AMD and Retinal Vascular Disease – Peter K. Kaiser, MD
Perioperative and Intraoperative OCT – Justis P. Ehlers, MD
Imaging the Uveitis Patient –Sunil K. Srivastava, MD
Remote Monitoring for AMD Management –Rishi P. Singh, MD
Advances in OCT Technology – Justis P. Ehlers, MD
PANEL: Imaging Case Discussion – Justis P. Ehlers, MD


  • Imaging Part I

    Drs. Kaiser, Ehlers, and Srivastava
  • Imaging Part II

    Drs. Singh, and Ehlers

Target Audience
This activity is intended to meet the needs of retina specialists, comprehensive ophthalmologists, retina fellows and healthcare providers who are interested in applying the most recent advancements in the retinal medicine field, including emerging techniques for imaging and treating retinal and vitreoretinal diseases.


Learning Objectives
Upon completion of this educational activity, participants should be able to:

  • Identify therapeutic options for the management of treatment-resistant AMD
  • Integrate available technologies into clinical practice for early detection, disease typing, and disease monitoring
  • Provide an overview of potential advances in OCT imaging
  • To discuss novel approaches to the use of OCT
  • Review imaging approaches to retinal disease and various insights on imaging technologies.


Criteria for Success
In order to receive credit, participants should watch the entire video. Statements of credit will be awarded upon successful completion of the post test and online evaluation/claim credit form. If you have questions about this CME activity, please contact AKH Inc. at

 CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.



Justis P. Ehlers, MD

  • Consultant

Alcon, Thrombogenics, Santen, Zeiss, Alimera, Leica, Genentech

  • Contracted Research

Alcon, Genentech, Regeneron

Peter K. Kaiser, MD

  • Consultant

Alcon, Allergan, Allegro, Aerpio, Bausch and Lomb, Bayer, Benitec, Biogen Idec, Boehringer Ingelheim, Carl Zeiss Meditec, Clearside, Eyevensys, Ocunexus, Omeros, ONL, Regeneron, Novartis, Kanghong, Ophthotech, Ohr, Santen, SciFluor, Shire, Thrombogenics

Rishi P. Singh, MD

  • Consultant

Genentech, Regeneron, Allergan

  • Contracted Research

Genentech, Regeneron, Allergan, Apellis

Sunil K. Srivastava MD

  • Consultant

Allergan, Santen, Sanofi, Regeneron, Zeiss, Bausch and Lomb



Dorothy Caputo, MA, BSN, RN – CE Director of Accreditations

-Nothing to disclose

MCME Global Staff and Planners

-Nothing to disclose

AKH Planners and Reviewers

-Nothing to disclose


Commercial Support
This activity is supported by an educational grant from Alcon, Genentech and Regeneron.



It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.


Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and MCME Global, Inc.

Advancing Knowledge in Healthcare    mcme-logo



Please answer the following pre-question before moving on to the session presentation.

First Name*
Last Name*

All of the following are considered advantages for home monitoring of AMD except for:

Decreased patient visits
Better adherence to treat and extend treatment
Reduced socioeconomic costs to patients and caregivers
Ability to predict progression to geographic atrophy